NCT05443971View on ClinicalTrials.gov

Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

PHASE2RecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

August 4, 2026

Study Completion Date

August 4, 2031

Conditions
Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
Interventions
BIOLOGICAL

Durvalumab

Given IV

RADIATION

Radiation Therapy

Undergo grid therapy

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER